23andMe Holding Co (ME)
0.5018
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
0.491
-0.01
(-2.15%)
After-Hours: 18:30
23andMe Cash from Financing (TTM): 4.19M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 4.19M |
September 30, 2023 | 4.074M |
June 30, 2023 | 8.13M |
March 31, 2023 | 9.777M |
December 31, 2022 | 12.69M |
September 30, 2022 | 18.48M |
Date | Value |
---|---|
June 30, 2022 | 14.17M |
March 31, 2022 | 546.00M |
December 31, 2021 | 575.34M |
September 30, 2021 | 653.45M |
June 30, 2021 | 687.68M |
March 31, 2021 | 155.34M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
4.074M
Minimum
Sep 2023
687.68M
Maximum
Jun 2021
224.11M
Average
16.33M
Median
Cash from Financing (TTM) Benchmarks
RadNet Inc | 195.64M |
DermTech Inc | 6.079M |
iSpecimen Inc | 0.0709M |
Sera Prognostics Inc | 0.752M |
Invitae Corp | -137.67M |